Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Refex Group is a diversified Indian conglomerate with active commercial operations across refrigerant gases, renewable energy, coal and ash handling, power trading, medical imaging equipment, pharmaceutical APIs for central nervous system indications, electric vehicles as a service, and airport retail. In healthcare-related verticals, it manufactures digital X-ray systems and flat panel detectors and refurbishes MRI machines. Its pharma division focuses on CNS APIs. The group has two publicly listed entities on Indian stock exchanges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Refex Group.